Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 6.588B
March 31, 2026 6.50B
December 31, 2025 6.547B
September 30, 2025 6.749B
June 30, 2025 6.775B
March 31, 2025 6.353B
December 31, 2024 6.096B
September 30, 2024 6.523B
June 30, 2024 5.942B
March 31, 2024 6.056B
December 31, 2023 6.223B
September 30, 2023 6.134B
June 30, 2023 7.42B
March 31, 2023 7.48B
December 31, 2022 7.289B
September 30, 2022 6.745B
June 30, 2022 7.14B
Date Value
March 31, 2022 7.612B
December 31, 2021 7.508B
September 30, 2021 7.682B
June 30, 2021 7.98B
March 31, 2021 8.007B
December 31, 2020 8.476B
September 30, 2020 8.344B
June 30, 2020 6.652B
March 31, 2020 6.662B
December 31, 2019 5.547B
September 30, 2019 5.488B
June 30, 2019 5.266B
March 31, 2019 5.196B
December 31, 2018 5.198B
September 30, 2018 5.137B
June 30, 2018 7.587B

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 3.148B
Eli Lilly & Co. 33.88B
ANI Pharmaceuticals, Inc. 597.21M
EyePoint, Inc. 166.41M
Amylyx Pharmaceuticals, Inc. 239.17M

Shareholders Equity (Quarterly) Related Metrics